logo
Select company
Select metric
7.44Price to Sales
VS
Market
17
Sector
34
Industry
57
History
81
$ 18.32Close
$ 9.44 - $ 18.62 52-Week Range
Ticker Information

Ticker

ZYME

Company Name

ZYMEWORKS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZYMEWORKS INC - Price to Sales Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZYME - P/S Historical data
DateMarket CapitalizationPrice to SalesRevenues
6/30/2025$ 914.02M7.44$ 122.87M
3/31/2025$ 788.82M8.45$ 93.38M
12/31/2024$ 917.02M12.02$ 76.3M
9/30/2024$ 943.62M15.17$ 62.2M
6/30/2024$ 718.29M11.46$ 62.7M
3/31/2024$ 636.34M12.61$ 50.46M
12/31/2023$ 863.05M11.35$ 76.01M
9/30/2023$ 515.91M1.12$ 461.58M
6/30/2023$ 526.34M1.18$ 447.7M
3/31/2023$ 562.14M1.26$ 446.14M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZYMEWORKS INC's latest trailing twelve months (TTM) P/S stands at 73.17.
  • Over the past 5 years, ZYMEWORKS INC's average P/S has been 21.53.
  • The median P/S for ZYMEWORKS INC during this period was 12.36
  • ZYMEWORKS INC reached its highest P/S over the past 5 years at 73.17.
  • The lowest P/S recorded by ZYMEWORKS INC in the same timeframe 1.12

ZYMEWORKS INC's P/S vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/S Benchmarks
CompanyP/S
CRMD : CORMEDIX INC 6.64NAGE : NIAGEN BIOSCIENCE INC 6.45URGN : UROGEN PHARMA LTD 9.13ANAB : ANAPTYSBIO INC 5.12PHAT : PHATHOM PHARMACEUTICALS INC 5.85GERN : GERON CORP 5.39SNDX : SYNDAX PHARMACEUTICALS INC 11.44NRIX : NURIX THERAPEUTICS INC 9.98GYRE : GYRE THERAPEUTICS INC 6.64XNCR : XENCOR INC 3.64

Definition of Price to Sales

[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Market Cap / Revenues
(=) P/S
P/S for ZYMEWORKS INC is calculated as follows: Market Cap [ $ 1.84B ] / Revenues [ $ 25.15M ]
(=) P/S [ 73.17 ]

ZYME - Price to Sales, Last 5 years

1.12

Minimum

Sep 30, 2023

73.17

Maximum

Sep 30, 2020

21.53

Average

12.36

Median

P/S Benchmark Analysis

The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
filtered constituents3.42K
min0
max11.15
average2.62
median1.97
std2.38